CME Information: 2.0 Credits; 2.0 ABIM MOC Points
Expiration Date: March 31, 2019
You must be logged in and own this product in order to post comments.
“Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography”
CME Information: 2.0 credits
Release date: March 2018 Valid through: March 2019
Introduction/Statement of Need:
The use of ultrasound enhancing agents (UEAs) has become an integral component of echocardiography practice. Since the 2008 American Society of Echocardiography (ASE) consensus statement on clinical applications of ultrasound contrast agents, there have been several important developments that require the document be revised into a guidelines paper. This update focuses on the new data that have been published and how these data, when combined with the 2008 consensus statement and 2014 ASE contrast sonography guidelines have led to specific recommendations for UEA use in different clinical settings.
This activity is designed for all cardiac sonographers and cardiovascular physicians with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, intensivists, and other medical professionals.
At the end of this article the reader will better be able to:
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Echocardiography designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC point in the American Board of Internal Medicine's (ABIM). Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ARDMS, CCI and Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.
The American Society of
Echocardiography is committed to ensuring that its educational mission and all
sponsored educational programs are not influenced by the special interests of
any corporation or individual, and its mandate is to retain only those authors
whose financial interests can be effectively resolved to maintain the goals and
educational integrity of the activity. While a monetary or professional
affiliation with a corporation does not necessarily influence an author’s
presentation, the Essential Areas and policies of the ACCME require that any
relationships that could possibly conflict with the educational value of the
activity be resolved prior to publication and disclosed to the audience.
Disclosures of faculty and commercial support relationships, if any, have been
Thomas R. Porter, MD, FASE (Chair); Sharon L. Mulvagh, MD, FASE (Co-Chair); Sahar S. Abdelmoneim, MBBCH, MSc, MS, FASE; Harald Becher, MD, PhD; J. Todd Belcik, BS, ACS, RDCS, FASE; Michelle Bierig, MPH, ACS, RDCS, FASE; Jonathan Choy, MD, MBA, FASE; Nicola Gaibazzi, MD, PhD; Linda D. Gillam, MD, MPH, FASE; Rajesh Janardhanan, MD, MRCP, FASE; Shelby Kutty, MD, PhD, MHCM, FASE; Howard Leong-Poi, MD, FASE; Jonathan R. Lindner, MD, FASE; Michael L. Main, MD, FASE; Wilson Mathias, Jr., MD; Margaret M. Park, BS, ACS, RDCS, RVT, FASE; Roxy Senior, MD, DM; and Flordeliza Villanueva, MD
According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.
The following authors reported no actual or potential conflicts of interest in relation to this document:
Sahar S. Abdelmoneim, MBBCH, MSc, MS, FASE; Michelle Bierig, MPH, ACS, RDCS, FASE; Linda D. Gillam, MD, FASE; Shelby Kutty, MD, PhD,MHCM,FASE; Wilson Mathias, Jr.,MD; Flordeliza Villanueva, MD.
The following authors reported relationships with one or more commercial interests:
Thomas R. Porter, MD, FASE has received educational support from Bracco Imaging and is a speaker at Bracco Imaging educational programs. He has received prior grant support from Lantheus Medical and GE Healthcare. He has received equipment support from Philips Healthcare. Sharon L. Mulvagh, MD, FASE has served as a consultant for Bracco Diagnostics and has received investigator-initiated research grants from GE Healthcare, Lantheus Medical Imaging, and Bracco Diagnostics. Harald Becher,MD, PhD has received research support (software), a research grant, and an honorarium for satellite symposia and courses from Bracco and research support (software) from Siemens and Philips. J. Todd Belcik, BS, ACS, RDCS, FASE has presented talks on behalf of Bracco. Jonathan Choy, MD, MBA, FASE has served as a course director and speaker and has received an unrestricted educational grant from Philips Healthcare, has served as a consultant for Bracco Imaging, and was on the advisory board for Aspen Canada. Nicola Gaibazzi, MD, PhD has served as a lecturer and consultant and has participated in sponsored studies for Bracco Imaging. Rajesh Janardhanan MD, MRCP, FASE has served on the speakers bureau for Lantheus. Howard Leong-Poi, MD, FASE has served on the speakers bureau for Lantheus and as a site investigator for a clinical trial run for Bracco Imaging. Jonathan R. Lindner, MD, FASE has received an investigator-initiated grant from GE Healthcare. Michael L. Main, MD, FASE has received research grants from Bracco Imaging and Boston Scientific and has served as a consultant for Boston Scientific. Margaret M. Park, BS, ACS, RDCS, RVT, FASE has served on the speakers bureau for Lantheus Medical and was a Sonographer Contrast Task Force member for Bracco Imaging. Roxy Senior, MD, DM has received speaking fees from Philips Healthcare, Bracco Imaging, and Lantheus Medical Imaging.
The following 2017-2018 ASE Board of
Directors, Guidelines and Standards Committee and a representative for the
Society for Cardiovascular Magnetic Resonance reviewed this document and reported
no actual or potential conflicts of interest in relation to this document:
Reviewers included Bonita Anderson, MApplSC, DMU, AMS, ACS, AFASA, FASE; Federico Asch, MD, FASE; Stephen Little, MD, FASE; Azin Alizadehasl, MD, FASE; Kim Baker, BS, RDCS, RVT, FASE; Scott Choyce, RDCS, RVT, RDMS, FASE; Frederick Cobey, MD, FASE; Benjamin W. Eidem, MD, FASE; Mark Friedberg, MD, FASE; Edward Gill, MD, FASE; Neal Gerstein, MD, FASE; Yvonne Gilliland, MD, FACC, FASE; Robi Goswami, MD, FASE; Lanqi Hua, RDCS, (AE/PE/FE), FASE; Renuka Jain, MD, FASE; Pei-Ni Jone, MD, FASE; James Kirkpatrick, MD, FASE; Allan L. Klein, MD, FASE; Stephen H. Little, MD, FASE; Elizabeth McIlwain, MPH, RCS, FASE; Maryellen H. Orsinelli, RN, RDCS, FASE; Alan Pearlman, MD, FASE; Andy Pellett, PhD, RCS, RDCS, FASE; Dermot Phelan, MD, PhD, FACC, FASE; Michael Picard, MD, FASE; Sue D. Phillip, RCS, FASE; Sorin Pislaru, MD, PhD, FASE; Juan Carlos Plana, MD, FASE; Charlene Porcelli, RDCS, RDMS, FASE; Geoffrey Rose, MD, FASE; David Rubenson, MD, FASE; Liza Sanchez, RCS, FASE; Fadi Shamoun, MD, FASE; Elaine Shea, ACS, RCS, RCCS, FASE; Madhav Swaminathan, MD, FASE; James D. Thomas, MD, FASE; David Wiener, MD, FASE
The following board and guidelines and standards committee members reported relationships with one or more commercial interests:
Alicia Armour, BS, MA, RDCS, FASE – Philips Healthcare (Speakers Bureau); Jao Cavalcante, MD, FASE – Medtronic Inc. (Grants or Research Support); Keith Collins, MS, RDCS, FASE – IBM (Stockholdership); Sabe De, MD, FASE – Bayer (Speakers Bureau); Astra Zeneca (Speakers Bureau); Craig Fleishman, MD, FASE – W.L. Gore Echo Core Lab (Scientific Advisory Committee); John Gorcsan III, MD, FASE - Medtronic (Research Grant Support, Including PI); Hitachi Aloka (Research Grant Support, including PI); GE (Research Grant Support, Including PI); Steve Heitner, MD, FASE – Bracco Diagnostics (Scientific Advisory Committee); Alnylam Pharmaceuticals (Scientific Advisory Committee); Amgen Pharmaceuticals (Scientific Advisory Committee); Takeda Pharmaceuticals (Scientific Advisory Committee); MyoKardia (Scientific Advisory Committee); Jonathan Lindner, MD, FASE – GE Healthcare (Research Grant Support, Including PI); Rick Meece, ACS, RDCS, RCS, RCIS, FASE – Philips Healthcare (Speakers Bureau); Abbott Medical (Speakers Bureau); Edwards Lifesciences (Speakers Bureau); William Perez, MD, FASE – Alibaba Holdings (Stockowernership); Myriad Genetics (Stockownership), American Energy Industries (Stockownership); Vera H. Rigolin, MD, FASE – Pfizer (Stockownership); Raymond Stainback, MD, FASE – GE (Stockownership); Douglas Shook, MD, FASE – Edwards Life Sciences (Research Grant Support, Including PI); Liva-Nova (Education); Boston Scientific (Education); Edwards Lifesciences (Consultant/Advisor)
The following ACCME reviewers, ASE Staff and CME editors reported no actual or potential conflicts of interest in relation to this document:
Pricilla Peters, BA, RDCS; Richard Brandon Stacey, MD, FASE; Richard Weiss, MD, FASE; Mary Lawson; and Christina LaFuria
The following ACCME reviewers, ASE Staff and CME editors reported relationships with one or more commercial interests:
Method of Participation: Online Only
Estimated Time to Complete this Activity: 2.0 hours
Receiving CME Credit:
To receive online CME credit for this activity, read the full activity then complete the posttest and evaluation. A score of 70% or higher is required for successful completion. You will be able to print your CME certificate immediately following successful completion of the posttest and evaluation.
You will need a compatible browser like Mozilla FireFox, Google Chrome or safari to view the content. Internet Explorer may not work.
This report is made available by ASE as a courtesy reference source for members. This report contains recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in this report are primarily based on the opinions of experts, rather than on scientifically verified data. ASE makes no express or implied warranties regarding the completeness or accuracy of the information in this report, including the warranty of merchantability or fitness for a particular purpose. In no event shall ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician patient relationship between ASE and your patients or anyone else.
Copyright American Society of Echocardiography. Questions? Contact us at email@example.com